On the 9th of November, ARM (Alliance for Regenerative Medicine) together with Catapult (a British organisation for cell- and gene therapy) will organise an investor day in London to present interesting and innovative companies at research’s forefront.
Among those companies selected is CombiGene, which will be presented by the company’s chief executive, Jan Nilsson. The meeting is open for selected investors and the media.
Jan Nilsson, VD
Tel: +46 (0)704 66 31 63